Avicanna Inc.

See all company news

• (09.Jun.2022) Avicanna's Subsidiary Santa Marta Golden Hemp Completes First Commercial Export of Feminized Cannabis Seeds to Lesotho
• (24.May.2022) Avicanna Subsidiary Santa Marta Golden Hemp S.A.S. Completes First Commercial Export of Aureus Branded THC and CBD Extracts to Portugal
• (13.May.2022) Avicanna Reports Q1 2022 Financial Statement and Management Change
• (06.May.2022) Avicanna Announces Closing of Strategic Private Placement
• (13.Apr.2022) Avicanna Enters into Exclusive License and Supply Agreement with Major South American Pharmaceutical Company
• (05.Apr.2022) Avicanna Expands Its Derma-Cosmetics Brand Pura H&W into the European Union Through a Partnership with Bio-Gate AG
• (01.Apr.2022) Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2021
• (31.Mar.2022) Avicanna Announces Closing of Non-Brokered Private Placement
• (14.Feb.2022) Tetra Bio-Pharma Enters Into a Strategic Partnership With Avicanna
• (02.Feb.2022) Avicanna Provides Q4-2021 Results and Corporate Highlights as Well as Fiscal 2022 Guidance
• (28.Jan.2022) Avicanna Announces Closing of Non-Brokered Private Placement of Convertible Debenture Units
• (14.Jan.2022) Avicanna Enters Master Supply Agreement With Chilean Pharmaceutical Pioneer Knop Laboratorios S.A
• (24.Dec.2021) Avicanna Completes First Commercial Export of CBG from Colombia to Czech Republic
• (06.Dec.2021) Avicanna Files a Patent to Protect Its Advanced Oral Cannabinoid Platform and Its Applications for Neurological Diseases
• (30.Nov.2021) Avicanna Enters into an Intellectual Property Licensing and Distribution Agreement with Established Pharmaceutical Company in Argentina
• (26.Nov.2021) MediPharm Labs Completes Medical Cannabis Export to Barbados
• (09.Nov.2021) Viola Brands Launches Nationwide in Canada Through the Medical Cannabis by Shoppers Online Platform
• (08.Nov.2021) Avicanna Inc. to Host Third Quarter 2021 Investor Conference Call on November 12 and Announces Warrant Repricing
• (04.Nov.2021) Avicanna's Subsidiary Obtains Good Agricultural and Collection Practices (“GACP”) Certification in Colombia
• (22.Oct.2021) Avicanna Completes Commercial Export of CBD Isolate and CBD Full Spectrum Psychoactive Derivatives From Colombia to Chile
• (19.Oct.2021) Avicanna Closes Non-Brokered Private Placement Raising $3.9 Million and Announces Warrant Repricing
• (01.Oct.2021) Avicanna Completes First Commercial Export of Feminized Cannabis Seeds from Colombia to Peru and Argentina
• (24.Sep.2021) Avicanna Files US Patent Application for a Novel Cannabinoid Formulation in Reducing Incidence of Seizures and Sudden Unexpected Death in Epilepsy
• (16.Sep.2021) Avicanna Completes Registration and Commercial Export of Its Evidence-Based CBD Dermacosmetics Brand, Pura Earth, in Ecuador
• (10.Sep.2021) Avicanna Announces Filing of Interim Financial Statements for Period Ended June 30, 2021 and Provides Corporate Update
• (27.Aug.2021) Avicanna Completes First Commercial Export of Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts to Brazil
• (23.Aug.2021) Avicanna Expands Sales of Pura Earth and RHO Phyto Branded Topicals into Alberta's Retail Channels
• (11.Aug.2021) Heritage Cannabis Enters Exclusive Partnership to Commercialize Avicanna's Evidence-Based Topical Products Through Heritage's Medical Opticann Brands
• (03.Aug.2021) Avicanna Completes First Commercial Export of Aureus Branded THC Active Pharmaceutical Ingredients to Peru
• (03.Aug.2021) Avicanna Announces Partial Revocation of Cease Trade Order and Proposed Financing
• (28.Jul.2021) Avicanna Completes First Commercial Export of Aureus Branded THC Extracts to Austria and Welcomes Colombian Government's Progressive New Regulation on Cannabis
• (16.Jul.2021) Avicanna Announces Change of Auditor
• (07.Jul.2021) Avicanna Executes Multi Year Agreement to Supply Brazilian Pharmaceutical Company With THC and CBD Cannabis Extracts